维普期刊资源整合服务平台（V6.5）

260篇 您的检索式：期刊名="Cancer Med"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	Is there a progression-free survival benefit of first-line Crizotinib versus standard chemotherapy and second-line Crizotinib in ALK-positive advanced lung adenocarcinoma?A retrospective study of Chinese patients显示文摘	Cui S Zhao Y Dong L	2016	Cancer Med2016，5，6：	1
2	Chemoresistance in non-small cell lung cancer显示文摘	Seve P Dumontet C	2005	Curr Med Chem Anti Cancer Agents2005，5，1：	1
3	Biological effects of eurcumin and its role in cancer cheraoprevention and therapy 显示文摘	Singh S Khar A	2006	Anti- cancer Agents Med Chem2006，6，3：	1
4	The changing face of thyroid cancer in a population-based cohort 显示文摘	Pathak KA Leslie WD Klonisch TC	2013	Cancer Med2013，2，4：	1
5	PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer显示文摘	Manceau G Marisa L Boige V	2015	Cancer Med2015，4，3：	1
6	Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal eaneer cells 显示文摘	Fan F Samuel S Evans KW	2012	Cancer Med2012，1，1：	1
7	Bisebromoamide, an extract from lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells显示文摘	Suzuki K Mizuno R Suenaga K	2013	Cancer Med2013，2，1：	1
8	Berberine Interfered with breast cancer cells metabolism, balancing energy homeostasis 显示文摘	Tan W Li N Tan R	2014	Anti- cancer Agents Med Chem2014，15，1：	1
9	Prognostic signature of protoeadherin 10 methylation in euratively reseeted pathological stage I non-small-cell lung cancer 显示文摘	Harada H Miyamoto K Yamashita Y	2015	Cancer Med2015，4，10：	1
10	EGFR, KRAS, BRAF and HER-2 molecular status in brain metastases from 77 NSCLC patients 显示文摘	Villalva C Duranton-Tanneur V Guilloteau K	2013	Cancer Med2013，2，3：	1
11	Histone methylation-mediated silencing of miR-139enhances invasion of non-small-cell lung cancer显示文摘	Watanabe K Amano Y Ishikawa R	2015	Cancer Med2015，4，10：	1
12	Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor 显示文摘	Fifis T Nguyen L Malcontenti-Wilson C	2013	Cancer Med2013，2，5：	1
13	Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevaeizumab 显示文摘	Price TJ Hardingham JE Lee CK	2013	Cancer Med2013，2，3：	1
14	Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors:a randomized phase I study显示文摘	Winer ES Safran H Karaszewska B	2015	Cancer Med2015，4，1：	1
15	Intraperitoneal injection of in vitro expanded vγgvδ2 T cells together with zoledronate for the treat- ment of malignant ascites due to gastric cancer 显示文摘	Wada I Matsushita H Noji S	2014	Cancer Med2014，3，2：	1
16	Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: An update meta-analysis显示文摘	Jiang T Min W Li Y	2016	Cancer Med2016，5，6：	1
17	Intravenous ascorbate as a tumor cytotoxic chemotherapeutic agent显示文摘	Riordan NH Riordan HD Meng X	2002	Med Hupotheses Clin Cancer Res2002，8，12：	1
18	Breast cancer molecular sub- types and survival in a hospital-based sample in Puerto Rico显示文摘	Ortiz AP Frias O P6rez J	2013	Cancer Med2013，2，3：	1
19	Association of diabetes and perineural invasion in pancreatic cancer 显示文摘	Sahin IH Shama MA Tanaka M	2012	Cancer Med2012，1，3：	1
20	Palbociclib: an evidence - based review of its potential in the treatment of breastcancer显示文摘	CADOO KA GUCALP A TRAINA TA	2014	Breast Cancer (Dove Med Press)2014，6，：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示